Literature DB >> 25818569

Lung function predicts pulmonary complications regardless of the surgical approach.

Ruoyu Zhang1, Sang Mee Lee2, Chris Wigfield3, Wickii T Vigneswaran3, Mark K Ferguson4.   

Abstract

BACKGROUND: Although postoperative predicted forced expiratory volume in the first second and diffusing capacity of lung (ppoFEV1% and ppoDLCO%, respectively) have been identified as independent predictors of postoperative pulmonary complications after open lobectomy, it has been suggested that their predictive abilities may not extend to patients undergoing minimally invasive lobectomy.
METHODS: We evaluated outcomes in 805 patients undergoing isolated lobectomy through open (n = 585) or minimally invasive approaches (n = 220) using a prospective database. Demographic and physiologic data were extracted and compared with complications classified as pulmonary, cardiac, other, mortality, and any.
RESULTS: Patients included 428 women and 377 men; mean age was 65.0 years. Minimally invasive patients were older (66.6 versus 64.3 years, p = 0.006), had better ppoFEV1% (71.5% versus 65.6%, p < 0.001) and performance status (0,1 94.1% versus 88.4%, p = 0.017), and less often underwent induction therapy (0.5% versus 4.8%, p = 0.003). Pulmonary and other complications were less common after minimally invasive lobectomy (3.6% versus 10.4%, p = 0.0034; 8.6% versus 15.8%, p = 0.008). Operative mortality occurred in 1.4% of minimally invasive patients and 3.9% of open patients (p = 0.075). Pulmonary complication incidence was related to predicted postoperative lung function for both minimally invasive and open approaches. On multivariate analysis with stratification for stage, ppoFEV1% and ppoDLCO% were predictive of pulmonary complications for both minimally invasive and open approaches.
CONCLUSIONS: Our results suggest that the predictive abilities of ppoFEV1% and ppoDLCO% are retained for minimally invasive lobectomy and can be used to estimate the risk of pulmonary complications.
Copyright © 2015 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25818569     DOI: 10.1016/j.athoracsur.2015.01.030

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  10 in total

Review 1.  Clinical guidelines on perioperative management strategies for enhanced recovery after lung surgery.

Authors:  Shugeng Gao; Serena Barello; Liang Chen; Chun Chen; Guowei Che; Kaican Cai; Roberto Crisci; Antonio D'Andrilli; Andrea Droghetti; Xiangning Fu; Paolo Albino Ferrari; Hiran C Fernando; Di Ge; Guendalina Graffigna; Yunchao Huang; Jian Hu; Wenjie Jiao; Gening Jiang; Xiaofei Li; Hui Li; Shanqing Li; Lunxu Liu; Haitao Ma; Dongchun Ma; Guillermo Martinez; Giulio Maurizi; Kevin Phan; Kun Qiao; Majed Refai; Erino A Rendina; Guoguang Shao; Jianfei Shen; Hui Tian; Luca Voltolini; Jacopo Vannucci; Camilla Vanni; Qingchen Wu; Shidong Xu; Fenglei Yu; Song Zhao; Peng Zhang; Lanjun Zhang; Xiuyi Zhi; Chengchu Zhu; Calvin Ng; Alan D L Sihoe; Anthony M H Ho
Journal:  Transl Lung Cancer Res       Date:  2019-12

2.  Impact of pulmonary function on pulmonary complications after robotic-assisted thoracoscopic lobectomy.

Authors:  Christopher Cao; Brian E Louie; Franca Melfi; Giulia Veronesi; Rene Razzak; Gaetano Romano; Pierluigi Novellis; Neel K Ranganath; Bernard J Park
Journal:  Eur J Cardiothorac Surg       Date:  2020-02-01       Impact factor: 4.191

3.  Impact of Airflow Limitation on Comorbidities and Postoperative Complications in Patients Undergoing Thoracic Surgery: A Retrospective Observational Study.

Authors:  Kaku Yoshimi; Shiaki Oh; Kenji Suzuki; Yuzo Kodama; Mitsuaki Sekiya; Kuniaki Seyama; Yoshinosuke Fukuchi
Journal:  Ann Thorac Cardiovasc Surg       Date:  2016-03-01       Impact factor: 1.520

4.  Refined risk stratification for thoracoscopic lobectomy or segmentectomy.

Authors:  Ruoyu Zhang; Jürgen Dippon; Godehard Friedel
Journal:  J Thorac Dis       Date:  2019-01       Impact factor: 2.895

Review 5.  Integrative Approaches to Minimize Peri-operative Symptoms.

Authors:  Fahad Faruqi; Kathryn J Ruddy; Shanda Blackmon
Journal:  Curr Oncol Rep       Date:  2021-04-28       Impact factor: 5.075

6.  External validation of five predictive models for postoperative cardiopulmonary morbidity in a Chinese population receiving lung resection.

Authors:  Guanghua Huang; Lei Liu; Luyi Wang; Zhile Wang; Zhaojian Wang; Shanqing Li
Journal:  PeerJ       Date:  2022-02-09       Impact factor: 2.984

Review 7.  Rapid Recovery of Postoperative Pulmonary Function in Patients With Lung Cancer and Influencing Factors.

Authors:  Yang Fuzhi; Tang Dongfang; Fu Wentao; Wang Jing; Wu Yingting; Mo Nianping; Gao Wen; Shen Xiaoyong
Journal:  Front Oncol       Date:  2022-07-11       Impact factor: 5.738

8.  Disparities in Receiving Guideline-Concordant Treatment for Lung Cancer in the United States.

Authors:  Erik F Blom; Kevin Ten Haaf; Douglas A Arenberg; Harry J de Koning
Journal:  Ann Am Thorac Soc       Date:  2020-02

9.  Pre-operative lymphocyte-to-monocyte ratio as a predictor of overall survival in patients suffering from osteosarcoma.

Authors:  Tao Liu; Xuan-Cheng Fang; Zhen Ding; Ze-Gan Sun; Li-Ming Sun; Yi-Lian Wang
Journal:  FEBS Open Bio       Date:  2015-08-07       Impact factor: 2.693

10.  Prognostic performance of pre-treatment NLR and PLR in patients suffering from osteosarcoma.

Authors:  Wen-Kai Xia; Zhi-Li Liu; Dong Shen; Qing-Feng Lin; Jun Su; Wei-Dong Mao
Journal:  World J Surg Oncol       Date:  2016-04-29       Impact factor: 2.754

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.